Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Sanofi American Depositary Receipt is the U.S.-traded depositary security representing Sanofi, a global biopharmaceutical company headquartered in France. It provides American investors with access to Sanofi’s diversified healthcare business through a dollar-denominated instrument, while the company’s ordinary shares trade in Europe. Sanofi develops and markets prescription medicines and vaccines across major therapeutic areas, including immunology, oncology, rare diseases, neurology, and diabetes. The company also operates a consumer healthcare business that offers widely used over-the-counter products in multiple markets. Through its ADR program, Sanofi broadens its investor base and connects its international operations with U.S. capital markets. The receipt is part of a large multinational pharmaceutical platform focused on research, development, manufacturing, and commercialization of treatments used by patients, healthcare providers, and health systems worldwide.